Poloxime T16559
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Poloxime is a hydrolysis product of poloxin and is a non-ATP-competitive Plk1 inhibitor. It also has moderate Plk1 inhibitory activity.
CAS nr:
17302-61-3
Purity:
98%
Molecular Weight:
179,22
SMILES:
CC1=CC(C(C(C)C)=C/C1=N\O)=O
Formula:
C10H13NO2
Pathway:
Cell Cycle/Checkpoint
Target:
PLK
